| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/05/2002 | EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 06/05/2002 | EP1210072A1 Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 06/05/2002 | EP1210065A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1209986A1 Metal-containing compositions, preparations and uses |
| 06/05/2002 | EP1137438B1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/05/2002 | EP1023273B1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5ht1a receptors |
| 06/05/2002 | EP0871443B1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/05/2002 | EP0858338B1 Use of levo-enantiomers of medetomidine derivatives |
| 06/05/2002 | EP0813420B1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
| 06/05/2002 | EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders |
| 06/05/2002 | EP0752866B1 Medicaments for treating restenosis, comprising nitric oxide releasing polymers |
| 06/05/2002 | EP0724637B2 Corticotropin-releasing factor 2 receptors |
| 06/05/2002 | EP0629199B1 Indole derivatives as 5-ht1 agonists |
| 06/05/2002 | CN1352684A Vascular endothelial cell growth factor variants and use thereof |
| 06/05/2002 | CN1352651A Method for inhibiting macrophage infiltration using monoconal anti-alpha-D-antibodies |
| 06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
| 06/05/2002 | CN1352643A Novel method for producing doxazosin mesylate in a crystalline modification designated as form A |
| 06/05/2002 | CN1352640A Mutual prodrugs of amlodipine and atorvastatin |
| 06/05/2002 | CN1352638A Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 06/05/2002 | CN1352634A Process for preparing amlodipine benzenesulphonate |
| 06/05/2002 | CN1352571A Medicaments containing doxazosin-mesylate of crystalline modification D |
| 06/05/2002 | CN1352568A Water soluble compositions for bioactive lipophilic compounds |
| 06/05/2002 | CN1352565A Agent for treating visual cell function disorder |
| 06/05/2002 | CN1352563A Use of phyllanthus for targeted stimulation of the immune system |
| 06/05/2002 | CN1352554A IL-8 receptor antagaonists |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1351985A Process for producing veratryl alcohol and its use in food, drink and grape wind |
| 06/05/2002 | CN1351888A Method for producing anti-osteopontic antibody medicine and use |
| 06/05/2002 | CN1351881A Medicine for treating piles |
| 06/05/2002 | CN1351870A Blood circulation activating core |
| 06/05/2002 | CN1351866A Levo-potassium magnesium aspartate freeze drying powder injection and preparing method |
| 06/05/2002 | CN1085981C Nicotinic acid ester compounds and its salts, their preparation and medicine composition containing them |
| 06/04/2002 | US6399824 For therapy and prophylaxis of arrhythmias, cardiac infraction, ischemic conditions, angina pectoris, shock, for preserving and storing a transplant for surgical measure |
| 06/04/2002 | US6399797 Vitamin D analogues |
| 06/04/2002 | US6399782 Benzimidazole inhibitors of fructose 1,6-bisphosphatase |
| 06/04/2002 | US6399780 Kinase inhibitors; anticancer agents |
| 06/04/2002 | US6399766 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them |
| 06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
| 06/04/2002 | US6399653 Ring fused dihydropyrans, process for preparation and use thereof |
| 06/04/2002 | US6399648 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/04/2002 | US6399643 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom |
| 06/04/2002 | US6399637 Crystal modification of torasemide |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399634 Benzothiophene compounds, compositions, and methods |
| 06/04/2002 | US6399633 Flavopiridol; low dosage; vascular lesions after ballon or stent |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |
| 06/04/2002 | US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease |
| 06/04/2002 | US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists |
| 06/04/2002 | US6399619 Prevention and treatment of aids and viral infection by hiv |
| 06/04/2002 | US6399610 Nasal or oral treatment of heart failure; reduced occurance of headaches or palpitation |
| 06/04/2002 | US6399603 Therapeutic heterocycles |
| 06/04/2002 | US6399601 Antidiabetic agents; nervous system disorders; anticholesterol agents |
| 06/04/2002 | US6399590 Phosphoglycolipid and methods for its use |
| 06/04/2002 | US6399576 Administering dosage of batroxobin |
| 06/04/2002 | US6399376 Modulation of vascular cell adhesive molecule expression through oligonucleotide interactions |
| 06/04/2002 | US6399139 Controlling material handling |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | US6397849 Methods of ophthalmic administration |
| 06/04/2002 | CA2364108A1 Acylamino cyclopropane derivatives |
| 06/04/2002 | CA2302396C Allosteric adenosine receptor modulators |
| 06/04/2002 | CA2205198C Human neutrophil elastase inhibitors |
| 06/04/2002 | CA2119262C Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 06/04/2002 | CA2067929C Piperazine derivatives |
| 05/30/2002 | WO2002042777A2 Modulation of the interaction between evh1 domains |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/30/2002 | WO2002042321A2 Mixed fibrils |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/30/2002 | WO2002042303A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| 05/30/2002 | WO2002042302A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042300A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | WO2002042297A1 Piperidine compounds and medicinal use thereof |
| 05/30/2002 | WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 05/30/2002 | WO2002042295A2 Peptides as met-ap2 inhibitors |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002042291A1 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
| 05/30/2002 | WO2002042280A2 Pyrimidine derivatives |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002041928A1 Porous polymeric biomaterials, preparation method and uses |
| 05/30/2002 | WO2002041924A1 Nitric oxide donor compounds and methods of treatment using same |
| 05/30/2002 | WO2002041917A1 Ophthalmological preparations |
| 05/30/2002 | WO2002041912A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | WO2002041910A2 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | WO2002041907A1 The additive in food, drug, cosmetics for supplying $g(g) linolenic acid and the process of producing them |
| 05/30/2002 | WO2002041896A2 Use of thienopyrimidines |
| 05/30/2002 | WO2002041895A1 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 05/30/2002 | WO2002041893A1 Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers |
| 05/30/2002 | WO2002041890A1 Medicinal compositions |
| 05/30/2002 | WO2002041882A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |